The Human Paraoxonase Gene Cluster As a Target in the Treatment of Atherosclerosis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Antioxidants and Redox Signaling

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/ars.2010.3774PMID 21867409PMCID PMC3270057
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2013cited by this paper
• Inflammation in Atherosclerosis

  2012cited by this paper
• Paraoxonase 2 Deficiency Alters Mitochondrial Function and Exacerbates the Development of Atherosclerosis

  2011cited by this paper
• Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

  2011cited by this paper
• Paraoxonase 1 protects against protein N‐homocysteinylation in humans

  2010cited by this paper
• One Enzyme, Two Functions

  2010cited by this paper
• Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity

  2010cited by this paper
• Curcumin induces paraoxonase 1 in cultured hepatocytes in vitro but not in mouse liver in vivo

  2010cited by this paper
• No or only population-specific effect of PON1 on human longevity: a comprehensive meta-analysis.

  2010cited by this paper
• Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR-/- mice.

  2010cited by this paper
• Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice.

  2010cited by this paper
• HDL‐paraoxonase and Membrane Lipid Peroxidation: A Comparison Between Healthy and Obese Subjects

  2010cited by this paper
• Role of protein kinase C in pitavastatin-induced human paraoxonase I expression in Huh7 cells.

  2010cited by this paper
• The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.

  2010cited by this paper
• Hepatic effects of rosiglitazone in rats with the metabolic syndrome.

  2010cited by this paper
• Betaine protects chronic alcohol and omega-3 PUFA-mediated down-regulations of PON1 gene, serum PON1 and homocysteine thiolactonase activities with restoration of liver GSH.

  2010cited by this paper
• Effect of quercetin on paraoxonase 1 activity--studies in cultured cells, mice and humans.

  2010cited by this paper
• The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.

  2010cited by this paper
• Eplerenone administration has beneficial effect on hepatic paraoxonase 1 activity in diabetic mice.

  2010cited by this paper
• A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity.

  2010cited by this paper
• Effects of acetylsalicylic acid on serum paraoxonase activity, Ox-LDL, coenzyme Q10 and other oxidative stress markers in healthy volunteers.

  2010cited by this paper
• Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils.

  2010cited by this paper
• Paraoxonase 2 is down-regulated by the Pseudomonas aeruginosa quorumsensing signal N-(3-oxododecanoyl)-L-homoserine lactone and attenuates oxidative stress induced by pyocyanin.

  2010cited by this paper
• Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.

  2010cited by this paper
• Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK.

  2010cited by this paper
• Human Paraoxonase-1 Activity in Childhood Obesity and Its Relation to Leptin and Adiponectin Levels

  2010cited by this paper
• Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.

  2009cited by this paper
• Comparative expression analysis reveals differences in the regulation of intestinal paraoxonase family members.

  2009cited by this paper
• Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin.

  2009cited by this paper
• Determinants of variation in human serum paraoxonase activity

  2009cited by this paper
• The paraoxonase gene family and atherosclerosis

  2009cited by this paper
• Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta.

  2009cited by this paper
• Human Paraoxonase Gene Cluster Transgenic Overexpression Represses Atherogenesis and Promotes Atherosclerotic Plaque Stability in ApoE-Null Mice

  2009cited by this paper
• Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes

  2009cited by this paper
• Abstract 1608: Paraoxonase 2 Deficiency Alters Mitochondrial Function and Exacerbates the Development of Atherosclerosis

  2009cited by this paper
• Genetic Polymorphism in Paraoxonase 1 (PON1): Population Distribution of PON1 Activity

  2009cited by this paper
• Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice.

  2009cited by this paper
• Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates.

  2009cited by this paper
• Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.

  2009cited by this paper
• Activation of AMP-activated Protein Kinase Suppresses Oxidized Low-density Lipoprotein-induced Macrophage Proliferation*

  2009cited by this paper
• Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals

  2009cited by this paper
• Effect of Quercetin on Paraoxonase 2 Levels in RAW264.7 Macrophages and in Human Monocytes––Role of Quercetin Metabolism

  2009cited by this paper
• Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity.

  2009cited by this paper
• Paraoxonase: a multifaceted biomolecule.

  2009cited by this paper
• Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat.

  2009cited by this paper
• High plasma C‐reactive protein (CRP) is related to low paraoxonase‐I (PON‐I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus

  2009cited by this paper
• Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning

  2008cited by this paper
• Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.

  2008cited by this paper
• Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-l-Homoserine Lactone

  2008cited by this paper
• Clinical trials report

  2008cited by this paper
• Oxidized low‐density lipoprotein acts synergistically with β‐glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells

  2008cited by this paper
• Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism

  2008cited by this paper
• Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin** This study was supported by National Institutes of Health Grants RO1 HL-56353 and RO1 HL-069038. Published, JLR Papers in Press, June 2, 2008.

  2008cited by this paper
• The paraoxonase gene polymorphism in stroke patients and lipid profile

  2008cited by this paper
• Relationship of adiponectin to serum paraoxonase 1.

  2008cited by this paper
• The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.

  2008cited by this paper
• Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study

  2008cited by this paper
• The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.

  2008cited by this paper
• Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties.

  2008cited by this paper
• Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis.

  2008cited by this paper
• Clinical findings of Takotsubo cardiomyopathy: results from a multicenter international study

  2008cited by this paper
• Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.

  2008cited by this paper
• Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.

  2008cited by this paper
• Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities.

  2008cited by this paper
• Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study)

  2008cited by this paper
• Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome

  2008cited by this paper
• Immunohistochemical detection of N-homocysteinylated proteins in humans and mice.

  2008cited by this paper
• Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?

  2008cited by this paper
• Homocysteine levels, paraoxonase 1 (PON1) activity, and cardiovascular risk.

  2008cited by this paper
• Regulation and characteristics of vascular smooth muscle cell phenotypic diversity

  2007cited by this paper
• Orlistat increases serum paraoxonase activity in obese patients.

  2007cited by this paper
• [The pathogenic mechanism of homocysteine -induced endothelial nitric oxide synthase dysfunction and the antagonistic effects by folic acid].

  2007cited by this paper
• Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice

  2007cited by this paper
• The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase.

  2007cited by this paper
• Paraoxonase-2 Reduces Oxidative Stress in Vascular Cells and Decreases Endoplasmic Reticulum Stress–Induced Caspase Activation

  2007cited by this paper
• Decreased Obesity and Atherosclerosis in Human Paraoxonase 3 Transgenic Mice

  2007cited by this paper
• Adenovirus-Mediated Expression of Human Paraoxonase 3 Protects Against the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice

  2007cited by this paper
• Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells.

  2007cited by this paper
• Time-dependent modulation of rat serum paraoxonase 1 activity by fasting

  2007cited by this paper
• Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway

  2007cited by this paper
• ADMINISTRATION OF EXOGENOUS ERYTHROPOIETIN β AFFECTS LIPID PEROXIDATION AND SERUM PARAOXONASE‐1 ACTIVITY AND CONCENTRATION IN PREDIALYSIS PATIENTS WITH CHRONIC RENAL DISEASE AND ANAEMIA

  2007cited by this paper
• Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.

  2007cited by this paper
• Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis.

  2007cited by this paper
• In vivo effects of oral contraceptives on paraoxonase, catalase and carbonic anhydrase enzyme activities on mouse.

  2007cited by this paper
• Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.

  2007cited by this paper
• Protective Effects of Ginsenoside Rb1 on Human Umbilical Vein Endothelial Cells In Vitro

  2007cited by this paper
• Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation.

  2007cited by this paper
• Pistachio intake increases high density lipoprotein levels and inhibits low-density lipoprotein oxidation in rats.

  2007cited by this paper
• Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease.

  2007cited by this paper
• Plasma Homocysteine Levels and Late Outcome in Patients with Unstable Angina

  2007cited by this paper
• HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.

  2007cited by this paper
• Probucol Up-Regulates Paraoxonase 1 Expression in Hepatocytes of Hypercholesterolemic Rabbits

  2006cited by this paper
• A20 inhibits oxidized low‐density lipoprotein‐induced apoptosis through negative Fas/Fas ligand‐dependent activation of caspase‐8 and mitochondrial pathways in murine RAW264.7 macrophages

  2006cited by this paper
• Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.

  2006cited by this paper
• Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups.

  2006cited by this paper
• 5-Methyltetrahydrofolate Rapidly Improves Endothelial Function and Decreases Superoxide Production in Human Vessels: Effects on Vascular Tetrahydrobiopterin Availability and Endothelial Nitric Oxide Synthase Coupling

  2006cited by this paper
• Effects of Intranasal Estradiol Treatment on Serum Paraoxonase and Lipids in Healthy, Postmenopausal Women

  2006cited by this paper
• Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.

  2006cited by this paper
• Human Paraoxonase-1 Overexpression Inhibits Atherosclerosis in a Mouse Model of Metabolic Syndrome

  2006cited by this paper
• Paraoxonase-2 Deficiency Aggravates Atherosclerosis in Mice Despite Lower Apolipoprotein-B-containing Lipoproteins

  2006cited by this paper

• The Paraoxonase (PON) Gene Family in Health, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Other Diseases

  2025cites this paper
• Cell type-specific regulation of the pentose phoshate pathway during development and metabolic stress-driven autoimmune diseases: Relevance for inflammatory liver, renal, endocrine, cardiovascular and neurobehavioral comorbidites, carcinogenesis, and aging.

  2025cites this paper
• Proteomic signatures of pediatric cardiovascular and cardiometabolic traits demonstrate long-term modifiable drivers of adult disease

  2025cites this paper
• Role of paraoxonase 2 (PON2) as a potential biomarker and therapeutic target in cancer treatment

  2025cites this paper
• Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes

  2024cites this paper
• Comparative study of oxidative stress in cancer patients occupationally exposed to the mixture of pesticides

  2024cites this paper
• ASGR1 is a promising target for lipid reduction in pigs with PON2 as its inhibitor

  2024cites this paper
• Paraoxonases at the Heart of Neurological Disorders

  2023cites this paper
• The association of paraoxonase I gene polymorphisms Q192R (rs662) and L55M (rs854560) and its activity with metabolic syndrome components in fars ethnic group

  2023cites this paper
• mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.

  2023cites this paper
• ПОШИРЕНІСТЬ ПОЛІМОРФІЗМУ ГЕНА PON1-108C/T У ХВОРИХ З РІЗНИМИ ТИПАМИ ЕНЦЕФАЛОПАТІЙ

  2023cites this paper
• The Potential of Green Grape (Vitis vinifera L) Extract on Paraoxonase-3 Serum Levels in Rats were Given High Cholesterol Diet

  2023cites this paper
• Alteration of Blood Oxidative Stress Status in Patients with Thoracic Aortic Dissection: A Pilot Study

  2023cites this paper
• Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance

  2023cites this paper
• The Removal of Time–Concentration Data Points from Progress Curves Improves the Determination of Km: The Example of Paraoxonase 1

  2022cites this paper
• Insights into the role of paraoxonase 2 in human pathophysiology

  2022cites this paper
• Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines

  2022cites this paper
• Associação do Genótipo e Fenótipo da Paraoxonase-1 com Angiografia Positiva para Doença Arterial Coronariana

  2022cites this paper
• Chlorpyrifos and parathion regulate oxidative stress differentially through the expression of paraoxonase 2 in human neuroblastoma cell.

  2022cites this paper
• Production of highly soluble native human paraoxonase 2 with potential anti-biofilm property

  2022cites this paper
• A Brief Review of the Association between Genetic Polymorphisms of the Paraoxonase Family and Atherosclerosis

  2022cites this paper
• Redox signaling at the crossroads of human health and disease

  2022cites this paper
• Insights into the role of paraoxonase 2 in human pathophysiology

  2022cites this paper
• The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases

  2021cites this paper
• The effect of paraoxonase 1 (PON1) gene polymorphisms T(-107)C and L55M and diet composition on serum PON1 activity in women

  2021influential citation
• Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer’s disease

  2021cites this paper
• Evidence of Paraoxonases 1, 2, and 3 Expression in Human Ovarian Granulosa Cells

  2021cites this paper
• The Activity and Polymorphism of the PON1 in Patients with Chronic Liver Disease: a Systematic Review and Meta-analysis

  2021cites this paper
• Cloning, sequence analysis, and tissue expression of marmoset paraoxonase 1.

  2021cites this paper
• Fisetin Alleviates Neointimal Hyperplasia via PPARγ/PON2 Antioxidative Pathway in SHR Rat Artery Injury Model

  2021cites this paper
• Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies

  2021cites this paper
• Paraoxonase‐2: A potential biomarker for skin cancer aggressiveness

  2020cites this paper
• Analysis of the involvement of single nucleotide polymorphisms of redox-homeostasis genes in the development of isolated and comorbid cardioand cerebrovascular diseases

  2020cites this paper
• Micro‐ and macrovascular cardiac allograft vasculopathy in relation to 91 cardiovascular biomarkers in heart transplant recipients—An exploratory study

  2020cites this paper
• PON1 status and homocysteine levels as potential biomarkers for cardiovascular disease.

  2020cites this paper
• Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin

  2020cites this paper
• Aspirinin insan kaynaklı hepatoma hücrelerinde paraoksonaz enzimlerinin protein düzeylerine ve arilesteraz aktivitesine etkisi

  2019influential citation
• The Association of PON1 192 Q/R Polymorphism with the Risk of Idiopathic Male Infertility in Northern Iran

  2019cites this paper
• Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease

  2019cites this paper
• Effect of palmitate-induced steatosis on paraoxonase-1 and paraoxonase-3 enzymes in human-derived liver (HepG2) cells

  2019influential citation
• Ilex paraguariensis extract prevents body weight gain in rats fed a high-fat diet

  2019cites this paper
• Preliminary Analysis of PON3 rs2375003 Polymorphism in Pakistani Patients with Coronary Artery Disease

  2019cites this paper
• Association of PON2 and PON3 polymorphism with risk of developing cataract

  2019cites this paper
• Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders

  2019cites this paper
• Activity of Antioxidant Enzymes and Their Association with Lipid Profile in Mexican People without Cardiovascular Disease: An Analysis of Interactions

  2018cites this paper
• PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women.

  2018cites this paper
• Association between dementia and vascular disease-associated polymorphisms in a Tunisian population

  2018cites this paper
• The Association of PON1 192 Q/R Polymorphism with the Risk of Idiopathic Male Infertility in Northern Iran

  2018cites this paper
• Changes in lipid profile parameters and PON1 status associated with L55M PON1 polymorphism, overweight and exposure to tobacco smoke

  2018cites this paper
• Arylesterase activity of Paraoxonase 1 - prognostic factor for one-year survival in patients with acute myocardial infarction

  2018influential citation
• Association of genetic polymorphisms of PON1 and CETP with the presence of metabolic syndrome; the effects of genotypes on their serum activity and concentrations

  2018influential citation
• NRIP1 (nuclear receptor interacting protein 1)

  2018cites this paper
• The role of paraoxonase in cancer.

  2017cites this paper
• Paraoxonase and Arylesterase Levels in Behcet’s Disease and Their Relations with the Disease Activity

  2017cites this paper
• The Paraoxonase Gene Cluster Protects Against Abdominal Aortic Aneurysm Formation

  2017cites this paper
• A non-synonymous single nucleotide polymorphism in the paraoxonase 3 gene regulates meat quality in Berkshire pigs

  2017cites this paper
• Estado antioxidante del líquido folicular en mujeres sometidas a estimulación ovárica: implicaciones en la maduración folicular y en la fertilidad

  2017cites this paper
• Synthesis and evaluation of novel 2-[(1,2,4-triazol-3-yl)thio]acetamide derivatives as potential serum paraoxonase-1 (PON1) activators

  2017cites this paper
• Paraoxonase activities in human follicular fluid: role in follicular maturation.

  2017cites this paper
• Paraoxonase and atherosclerosis-related cardiovascular diseases.

  2017cites this paper
• Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise

  2016cites this paper
• SEQUENCE ANALYSIS OF SERUM PARAOXONASE 1 OF BATHYERGIDAE FAMILY SPECIFIC RATS

  2016cites this paper
• Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus.

  2016cites this paper
• Serum paraoxonase 1 activity in patients with iron deficiency anemia

  2016cites this paper
• Effets potentiels et mécanismes d'action antioxydant et anti-inflammatoire d'un apport nutritionnel de spirulines enrichies en silicium

  2015cites this paper
• Paraoksonaza 1 u bolesnika sa šećernom bolesti

  2015cites this paper
• Study the levels of Leptin, and Adiponectin with Paraoxonase in Obese Individuals (male & female)

  2015cites this paper
• Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents

  2015cites this paper
• Association of paraoxonase-1 activity and major depressive disorder in patients with metabolic syndrome

  2015influential citation
• Role of Paraoxonase Activity and Oxidative Stress in Renal Vascular Damage in Type 2 Diabetes Mellitus

  2015cites this paper
• Dietary silicon-enriched spirulina improves early atherosclerosis markers in hamsters on a high-fat diet.

  2015cites this paper
• The association of PON1 192 Q/R polymorphism and the risk of female infertility.

  2015cites this paper
• Paraoxonase 1 genotype-phenotype correlation in patients with metabolic syndrome.

  2015influential citation
• Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine

  2015cites this paper
• Gulf War illness: an overview of events, most prevalent health outcomes, exposures, and clues as to pathogenesis

  2015cites this paper
• Exploring the Role of Paraoxonases in the Pathogenesis of Coronary Artery Disease: A Systematic Review

  2014cites this paper
• Association of Cadmium, Lead and Mercury with Paraoxonase 1 Activity in Women

  2014cites this paper
• Inflammation, infection, cancer and all that…the role of paraoxonases.

  2014cites this paper
• Moderate chronic administration of Vineatrol-enriched red wines improves metabolic, oxidative, and inflammatory markers in hamsters fed a high-fat diet.

  2014cites this paper
• Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.

  2014cites this paper
• Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia.

  2014cites this paper
• Non-genetic factors influencing serum PON1 levels.

  2014cites this paper
• Mitochondria, endothelial cell function, and vascular diseases

  2014cites this paper
• Distribution of Paraoxonase 1 polymorphisms and activities in obese patients

  2013influential citation
• Evaluation of serum paraoxonase and arylesterase activities in subjects with asthma and chronic obstructive lung disease.

  2013cites this paper
• Inhibition of Serum PON Arylesterase Activity by Different Inhibitors and Correlation Analysis

  2013cites this paper
• Functionally Defective High-Density Lipoprotein and Paraoxonase: A Couple for Endothelial Dysfunction in Atherosclerosis

  2013cites this paper
• There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study

  2013cites this paper
• The genetic determinants of cardiovascular disease in patients with type 2 diabetes

  2013cites this paper
• Correlation between several extrinsic factors and Paraoxonase 1 activities.

  2013cites this paper
• Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.

  2013cites this paper
• Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation

  2012cites this paper
• Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease

  2012cites this paper
• Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients.

  2012cites this paper
• Knockdown of paraoxonase 1 expression influences the ageing of human dermal microvascular endothelial cells

  2012cites this paper
• Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease

  2012cites this paper
• Myeloperoxidase-Derived Chlorinating Species Induce Protein Carbamylation Through Decomposition of Thiocyanate and Urea: Novel Pathways Generating Dysfunctional High-Density Lipoprotein

  2012cites this paper